Clinical Trials
113 trialsMRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Centre Antoine Lacassagne
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
UNC Lineberger Comprehensive Cancer Center
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
Emory University
TEP-Curie
Centre Oscar Lambret
EVA DOPA
Centre Hospitalier Universitaire de Nīmes
FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
Barbara Ann Karmanos Cancer Institute
Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA
Thomas Jefferson University
An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer
M.D. Anderson Cancer Center
Resting-State Functional MRI in Glioma Patients Before and After Surgery
M.D. Anderson Cancer Center
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
University of Texas Southwestern Medical Center
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
M.D. Anderson Cancer Center
MR-ICANS
University Hospital, Montpellier
IMPACT
Queen Mary University of London
18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery
M.D. Anderson Cancer Center
PET Scan in Treating Patients With Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
FDG PET-MRI for the Diagnosis of Spinal Cord Lesions
M.D. Anderson Cancer Center
Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System
Emory University
Heads-Up
Nottingham University Hospitals NHS Trust
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
Fox Chase Cancer Center
Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
Vanderbilt-Ingram Cancer Center
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
University of Southern California
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
Jonsson Comprehensive Cancer Center
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
Ohio State University Comprehensive Cancer Center
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
M.D. Anderson Cancer Center
New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality
M.D. Anderson Cancer Center
Effects of Meditation on Cognitive Function and Quality of Life
M.D. Anderson Cancer Center
Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer
Barbara Ann Karmanos Cancer Institute
CIRCE
Centre Hospitalier Universitaire Dijon
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
OHSU Knight Cancer Institute
TEPARF
Institut Bergonié
Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study
M.D. Anderson Cancer Center
Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors
Stanford University
(MISAP)
Institut National de la Santé Et de la Recherche Médicale, France
ReIMAGINE Prostate Cancer Screening
University College, London
BARONET
NHS Tayside
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Abramson Cancer Center at Penn Medicine
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Case Comprehensive Cancer Center
Imaging Brain Tumors With FACBC and Methionine
Memorial Sloan Kettering Cancer Center
CIPN
University of Arizona
Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging
M.D. Anderson Cancer Center
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer
City of Hope Medical Center
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
In-Room PET in Proton Radiation Therapy
Massachusetts General Hospital
MIRABELLE
Royal Marsden NHS Foundation Trust
Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
Barbara Ann Karmanos Cancer Institute
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
Abramson Cancer Center at Penn Medicine